Tonix Pharmaceuticals and Southern Research Announce Expansion of COVID-19 Vaccine Collaboration
June 18, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Plan to Produce Blueprint of How the Human Immune System Responds to Infection Caused by SAR-CoV-2, the Virus that Causes COVID-19 Results Expected to Support Tonix’s Anticipated Regulatory Filings...
Tonix Pharmaceuticals Announces that Results from Preclinical Studies of TNX-1700 Will be Presented in a Poster at the AACR Virtual Annual Meeting 2020
June 17, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that preclinical...
Tonix Pharmaceuticals Announces Acquisition of Non-Addictive Migraine and Pain Treatment Programs from Trigemina and Assumption of License
June 11, 2020 14:43 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement...
Tonix Pharmaceuticals Announces Appointment of Richard H. Bagger to Board of Directors
June 10, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 10, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of...
Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences
June 03, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Company management will participate and host one-on-one...
Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be Manufacturing Partner for COVID-19 Vaccine Candidate TNX-1800
June 01, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, June 01, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement...
Tonix Pharmaceuticals Posted Results from Pharmacokinetic Analyses of TNX-102 SL and TNX-601 CR in Advance of Virtual Poster Presentations at the American Society of Clinical Psychopharmacology
May 21, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, posted two posters for the American...
Tonix Pharmaceuticals Announces Appointment of Herbert Harris, M.D., Ph.D., as Executive Vice President, Translational Medicine
May 19, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of...
Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights
May 12, 2020 07:30 ET
|
Tonix Pharmaceuticals Holding Corp.
Four Potential Vaccines in Development to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on the Company’s Horsepox Virus Vaccine Platform Potential Vaccine, TNX-801, in Development to...
Tonix Pharmaceuticals Enters into Research Collaboration and Exclusive License Agreement with University of Alberta to Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 and TNX-1830, for the Prevention of COVID-19
May 07, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, and the University of Alberta, a...